Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208988 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT00208988 is a NA study that has completed, run by Emory University. The registered enrollment target is 250 participants.
The verdict
NCT00208988, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
Prostate cancer is the most common type of cancer among men. It is also the second leading cause of cancer-related death among men. Two screening tests are available to try to detect prostate cancer early - the digital rectal examination (DRE) and the prostate specific antigen (PSA) blood test. Unfortunately, physicians aren't sure whether or not these two screening tests help save lives, and there's a lot of controversy about how to use them. Recently, a major government committee (the U.S. Preventive Services Task Force) recommended that physicians discuss the risks and potential benefits of prostate cancer screening with their patients, and allow patients to make their own decision. Because of the controversies, many physicians currently don't discuss prostate cancer with their patients. The problem is that it takes time and effort to have these discussions, and the information is complicated. A lot of patients have trouble understanding it, especially if they have a limited educational background or trouble reading. When patients have difficulty obtaining, understanding, and acting on basic health information, we say that they have "low health literacy." Other researchers have shown that patients with low health literacy don't know as much about cancer screening and are less likely to get screened for various cancers. They also tend to be timid about discussing things with their doctor, and often go along with what the doctor says, rather than taking an active role in the decision making. In 2003, under IRB approval, we conducted a study with 2 goals: 1) to encourage patients to talk to their doctor about prostate cancer screening, and 2) to learn more about the impact of low health literacy on these conversations. To promote conversation, we used two handouts, given to patients in the waiting room before they saw the doctor. The first was a patient education handout about prostate cancer screening, written in very simple terms with useful illustrations. The s
Interventions
- PROCEDURE Educational handout about prostate cancer screening
- PROCEDURE Simple cue for patient to talk to doctor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2003-05 |
| Est. Completion | 2003-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208988
The ClinicalTrials.gov registry entry for NCT00208988 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Educational handout about prostate cancer screening is the first listed.
NCT00208988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208988 about?
NCT00208988 is a clinical study titled "A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening". Prostate cancer is the most common type of cancer among men. It is also the second leading cause of cancer-related death among men. Two screening tests are available to try to detect prostate cancer early - the digital rectal examination (DRE) and the prostate specific antigen (PSA) blood test. Unfo...
What is the current status of trial NCT00208988?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2003-05. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00208988?
The interventions under investigation include: Educational handout about prostate cancer screening (PROCEDURE), Simple cue for patient to talk to doctor (PROCEDURE).
Who is sponsoring clinical trial NCT00208988?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.